Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul;53(7):1020-3.
doi: 10.1136/gut.2003.027086.

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

G Donati  1 , B Stagni, F Piscaglia, N Venturoli, A M Morselli-Labate, L Rasciti, L Bolondi
Affiliations

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

G Donati et al. Gut. 2004 Jul.

Abstract

Background: The conditions associated with fatty liver disease presenting with normal liver enzymes and the mechanism involved in its development remain to be fully elucidated.

Aims: The aim of the present study was to test the hypothesis that fatty liver with normal liver enzymes occurs more frequently in arterial hypertensive patients and to establish whether this condition is associated with insulin resistance.

Patients: A total of 55 non-obese, non-diabetic, non-heavy alcohol drinking patients with arterial hypertensive and normal liver enzymes and 55 sex and age matched healthy subjects were enrolled into the study.

Methods: Plasma metabolic parameters, body mass index, and the presence of fatty liver were investigated. Insulin resistance was estimated from plasma insulin and glucose as the homeostasis model assessment index. Stepwise logistic regression and multivariate regression analysis were used on the combined sample to identify variables independently associated with fatty liver and insulin resistance.

Results: Hypertensive patients had a significantly higher prevalence of fatty liver (30.9% v 12.7%; p<0.041), higher insulin resistance (mean 2.27 (SD 1.81) v 1.56 (0.70); p = 0.022), and slightly higher body mass index (24.9 (3.0) v 24.0 (2.2); p = 0.043) than controls. Multivariate logistic regression identified insulin resistance (odds ratio 1.66 (95% confidence interval (CI) 1.03-2.52)) and body mass index (OR 1.22 (95% CI 1.00-1.49)) as factors independently associated with fatty liver. Multivariate regression analysis showed insulin resistance to be predicted by alanine transaminase (p = 0.002), presence of arterial hypertension (p = 0.029), and body mass index (p = 0.048).

Conclusion: The higher prevalence of non-alcoholic fatty liver in non-obese hypertensive patients with normal liver enzymes appears to be related to increases in insulin resistance and body weight.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Homeostasis model assessment index (HOMA), an indicator of insulin resistance. Values are mean (SD) in hypertensive (Hypert) patients and control subjects subgrouped according to presence or absence of fatty liver. p values indicate significance level of differences between subjects with and without fatty liver in hypertensive patients and in controls, as calculated using the unpaired t test.
See this image and copyright information in PMC

Comment in

References

    1. Younossi Z , Diehl A, Ong J. Non alcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002;35:746–52. - PubMed
    1. Bellentani S , Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112–17. - PubMed
    1. Falck-Ytter Y , Younossi Z, Marchesini G, et al. Clinical features and natural history of non alcoholic steatosis syndromes. Semin Liver Dis 2001;21:17–26. - PubMed
    1. Teli M , James O, Burt A, et al. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714–19. - PubMed
    1. Powell E , Cookesley W, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74–80. - PubMed